Muhammad U. Wahab
Islamabad, IS, Pakistan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Real-World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From Pakistan.
Journal: Diabetes, obesity & metabolism
Published: May 05, 2026
Multicenter, Retrospective, observational study to evaluate the real-world use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in the Pakistani population with Type-2 diabetes (T2D).
Journal: Pakistan journal of medical sciences
Published: September 30, 2024
Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country.
Journal: International journal of environmental research and public health
Published: August 21, 2022
Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study.
Journal: BMC endocrine disorders
Published: April 12, 2022
Essential diagnostics and devices in primary care diabetes.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: September 28, 2021
Efficacy and Safety of Dulaglutide in Type 2 Diabetes Patients in Endocrinology Clinics of Islamabad, Pakistan.
Journal: Indian journal of endocrinology and metabolism
Published: September 16, 2021
Effectiveness, Safety, and Patient Satisfaction of Liraglutide in Type 2 Diabetic Patients.
Journal: Cureus
Published: August 31, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026